Treatment algorithms in refractory partial epilepsy
نویسندگان
چکیده
منابع مشابه
7.01.143 Responsive Neurostimulation for the Treatment of Refractory Partial Epilepsy
[TOP] Responsive neurostimulation (RNS) may be considered medically necessary for patients with partial epilepsy who meet ALL of the following criteria: Are 18 years or older. Have a diagnosis of partial-onset seizures with 1 or 2 well-localized seizure foci identified. Have an average of 3 or more disabling seizures (e.g., motor partial seizures, complex partial seizures, or secondary ge...
متن کاملClobazam as adjunctive treatment in refractory epilepsy.
IF~ ~~' Pyelograms from two identical twins. (a) Case 1, showing left chronic pyelonephritis; renal outlines have been pencilled in for clarity. (b) Case 2, showing normal appearances apart from a minor degree of duplex bilaterally. Case reports Case 1-This patient was investigated at the age of 18 for recurrent urinary infection. She had been aware of symptoms only for the preceding few months...
متن کاملMesial temporal structures and comorbid anxiety in refractory partial epilepsy.
We used quantitative magnetic resonance imaging (MRI) to examine the mesial temporal structures in subjects with refractory partial epilepsy and comorbid anxiety and found preservation with a right-sided preponderance. The findings indicate a role for this brain region in the genesis of anxiety.
متن کاملPremature mortality in refractory partial epilepsy: does surgical treatment make a difference?
BACKGROUND Epilepsy carries an increased risk of premature death. For some people with intractable focal epilepsy, surgery offers hope for a seizure-free life. The authors aimed to see whether epilepsy surgery influenced mortality in people with intractable epilepsy. METHODS The authors audited survival status in two cohorts (those who had surgery and those who had presurgical assessment but ...
متن کاملEconomic Evaluation of Add-on Levetiracetam for the Treatment of Refractory Partial Epilepsy in Korea
OBJECTIVE This study estimated the expected cost-effectiveness ratio expressed as the incremental cost per seizure-free day (SFD) gained and the incremental cost per quality adjusted life year (QALY) gained when using levetiracetam (LEV) as add-on therapy from a third-party payer perspective. METHODS A 1-year dose-escalation decision-tree model comparing LEV plus standard therapy (ST) with ST...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Epilepsia
سال: 2009
ISSN: 0013-9580,1528-1167
DOI: 10.1111/j.1528-1167.2009.02236.x